 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
The crystal structure of human procathepsin k
|
|
Structure:
|
 |
Protein (procathepsin k). Chain: a. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
2.60Å
|
R-factor:
|
0.214
|
R-free:
|
0.344
|
|
|
Authors:
|
 |
J.M.Lalonde,B.Zhao,W.W.Smith,C.A.Janson,R.L.Desjarlais, T.A.Tomaszek,T.J.Carr,S.K.Thompson,D.S.Yamashita,D.F.Veber, S.S.Abdel-Mequid
|
Key ref:
|
 |
J.M.LaLonde
et al.
(1999).
The crystal structure of human procathepsin K.
Biochemistry,
38,
862-869.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
27-Oct-98
|
Release date:
|
24-Oct-99
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P43235
(CATK_HUMAN) -
Cathepsin K
|
|
|
|
Seq: Struc:
|
 |
 |
 |
329 a.a.
310 a.a.
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.22.38
- Cathepsin K.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Broad proteolytic activity. With small-molecule substrates and inhibitors, the major determinant of specificity is P2, which is preferably Leu, Met > Phe, and not Arg.
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular space
|
3 terms
|
 |
|
Biological process
|
bone resorption
|
3 terms
|
 |
|
Biochemical function
|
protein binding
|
5 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
38:862-869
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
The crystal structure of human procathepsin K.
|
|
J.M.LaLonde,
B.Zhao,
C.A.Janson,
K.J.D'Alessio,
M.S.McQueney,
M.J.Orsini,
C.M.Debouck,
W.W.Smith.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Cathepsin K is a cysteine protease present in human osteoclasts that plays an
important role in bone resorption. Cathepsin K is synthesized as an inactive
proenzyme and activated under conditions of low pH. Autoproteolytic processing
of the N-terminal 99 amino acid propeptide produces the active, mature form of
cathepsin K. It is presumed that the activation of procathepsin K in vivo occurs
in the bone resorption pit, which has a low-pH environment. We have determined
the structure of human procathepsin K at 2.8 A resolution. The structure of the
mature enzyme domain within procathepsin K is virtually identical to that of
mature cathepsin K. The fold of the propeptide of procathepsin K is similar to
that observed in procathepsins B and L despite differences in length and
sequence. A portion of the propeptide occupies the active site cleft of
cathepsin K. Hydrophobic interactions, salt bridges, and hydrogen-bonding
interactions are observed in the structure of the propeptide and between the
propeptide and the mature enzyme of procathepsin K. These interactions suggest
an explanation for the stability of the proenzyme. The structure of procathepsin
K contributes to an understanding of the molecular basis of inhibition by the
propeptide portion of the molecule and activation of this important member of
the cysteine protease family.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.Reiser,
B.Adair,
and
T.Reinheckel
(2010).
Specialized roles for cysteine cathepsins in health and disease.
|
| |
J Clin Invest, 120,
3421-3431.
|
 |
|
|
|
|
 |
M.Fairhead,
and
L.Thöny-Meyer
(2010).
Role of the C-terminal extension in a bacterial tyrosinase.
|
| |
FEBS J, 277,
2083-2095.
|
 |
|
|
|
|
 |
R.M.Deshapriya,
S.Yuhashi,
M.Usui,
T.Kageyama,
and
Y.Yamamoto
(2010).
Identification of essential residues of CTLA-2alpha for inhibitory potency.
|
| |
J Biochem, 147,
393-404.
|
 |
|
|
|
|
 |
K.C.Pandey,
D.T.Barkan,
A.Sali,
and
P.J.Rosenthal
(2009).
Regulatory elements within the prodomain of falcipain-2, a cysteine protease of the malaria parasite Plasmodium falciparum.
|
| |
PLoS One, 4,
e5694.
|
 |
|
|
|
|
 |
K.Schilling,
A.Körner,
S.Sehmisch,
A.Kreusch,
R.Kleint,
Y.Benedix,
A.Schlabrakowski,
and
B.Wiederanders
(2009).
Selectivity of propeptide-enzyme interaction in cathepsin L-like cysteine proteases.
|
| |
Biol Chem, 390,
167-174.
|
 |
|
|
|
|
 |
A.F.Schilling,
C.Mülhausen,
W.Lehmann,
R.Santer,
T.Schinke,
J.M.Rueger,
and
M.Amling
(2007).
High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K.
|
| |
Osteoporos Int, 18,
659-669.
|
 |
|
|
|
|
 |
F.C.Reis,
T.F.Costa,
T.Sulea,
A.Mezzetti,
J.Scharfstein,
D.Brömme,
R.Ménard,
and
A.P.Lima
(2007).
The propeptide of cruzipain--a potent selective inhibitor of the trypanosomal enzymes cruzipain and brucipain, and of the human enzyme cathepsin F.
|
| |
FEBS J, 274,
1224-1234.
|
 |
|
|
|
|
 |
M.Kliemannel,
R.Golbik,
R.Rudolph,
E.Schwarz,
and
H.Lilie
(2007).
The pro-peptide of proNGF: structure formation and intramolecular association with NGF.
|
| |
Protein Sci, 16,
411-419.
|
 |
|
|
|
|
 |
G.Kaulmann,
G.J.Palm,
K.Schilling,
R.Hilgenfeld,
and
B.Wiederanders
(2006).
The crystal structure of a Cys25 -> Ala mutant of human procathepsin S elucidates enzyme-prosequence interactions.
|
| |
Protein Sci, 15,
2619-2629.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.Wieczerzak,
E.Jankowska,
S.Rodziewicz-Motowidło,
A.Giełdoń,
J.Lagiewka,
Z.Grzonka,
M.Abrahamson,
A.Grubb,
and
D.Brömme
(2005).
Novel azapeptide inhibitors of cathepsins B and K. Structural background to increased specificity for cathepsin B.
|
| |
J Pept Res, 66,
1.
|
 |
|
|
|
|
 |
A.Rossi,
Q.Deveraux,
B.Turk,
and
A.Sali
(2004).
Comprehensive search for cysteine cathepsins in the human genome.
|
| |
Biol Chem, 385,
363-372.
|
 |
|
|
|
|
 |
K.C.Pandey,
P.S.Sijwali,
A.Singh,
B.K.Na,
and
P.J.Rosenthal
(2004).
Independent intramolecular mediators of folding, activity, and inhibition for the Plasmodium falciparum cysteine protease falcipain-2.
|
| |
J Biol Chem, 279,
3484-3491.
|
 |
|
|
|
|
 |
D.N.Li,
S.P.Matthews,
A.N.Antoniou,
D.Mazzeo,
and
C.Watts
(2003).
Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo.
|
| |
J Biol Chem, 278,
38980-38990.
|
 |
|
|
|
|
 |
D.Turk,
and
G.Guncar
(2003).
Lysosomal cysteine proteases (cathepsins): promising drug targets.
|
| |
Acta Crystallogr D Biol Crystallogr, 59,
203-213.
|
 |
|
|
|
|
 |
S.Pietschmann,
M.Fehn,
G.Kaulmann,
I.Wenz,
B.Wiederanders,
and
K.Schilling
(2002).
Foldase function of the cathepsin S proregion is strictly based upon its domain structure.
|
| |
Biol Chem, 383,
1453-1458.
|
 |
|
|
|
|
 |
K.Schilling,
S.Pietschmann,
M.Fehn,
I.Wenz,
and
B.Wiederanders
(2001).
Folding incompetence of cathepsin L-like cysteine proteases may be compensated by the highly conserved, domain-building N-terminal extension of the proregion.
|
| |
Biol Chem, 382,
859-865.
|
 |
|
|
|
|
 |
K.Sol-Church,
J.Frenck,
and
R.W.Mason
(2000).
Mouse cathepsin M, a placenta-specific lysosomal cysteine protease related to cathepsins L and P.
|
| |
Biochim Biophys Acta, 1491,
289-294.
|
 |
|
|
|
|
 |
R.J.Riese,
and
H.A.Chapman
(2000).
Cathepsins and compartmentalization in antigen presentation.
|
| |
Curr Opin Immunol, 12,
107-113.
|
 |
|
|
|
|
 |
S.Kreusch,
M.Fehn,
G.Maubach,
K.Nissler,
W.Rommerskirch,
K.Schilling,
E.Weber,
I.Wenz,
and
B.Wiederanders
(2000).
An evolutionarily conserved tripartite tryptophan motif stabilizes the prodomains of cathepsin L-like cysteine proteases.
|
| |
Eur J Biochem, 267,
2965-2972.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|